1415 / 1542
I-125 permanent prostate brachytherapy
selection criteria
• Low or selected intermediate risk localised disease
• Life expectancy > 10 years
• Prostate volume < 50mls, if larger may need hormone
treatment prior to brachytherapy to shrink prostate
• Excluded
- if significant obstructive urinary symptoms (
urine peak flow
rate < 10mls per sec or large post-micturition residual volume
) as at
high risk of catheterisation
- previous Trans-Urethral Resection of Prostate (
TURP
)
resulting in large prostate defect